Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuhiro Tanaka

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
Kidney International|January 17, 2009
Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidneyIchiro Kojima, Tetsuhiro Tanaka, Reiko Inagi, et al.
American Journal of Physiology. Renal Physiology|June 4, 2010
Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stressFredrik Palm, Masaomi Nangaku, Angelica Fasching, et al.
Kidney International|March 16, 2020
The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney diseaseSho Hasegawa, Tetsuhiro Tanaka, Tomoyuki Saito, et al.
Scientific Reports|August 14, 2023
Chromatin remodeling factor, INO80, inhibits PMAIP1 in renal tubular cells via exchange of histone variant H2A.Z. for H2ARika Miura, Imari Mimura, Hanako Saigusa, et al.
Biochemical and Biophysical Research Communications|July 16, 2021
A novel method for successful induction of interdigitating process formation in conditionally immortalized podocytes from mice, rats, and humansKotaro Doi, Hiroshi Kimura, Takehiko Wada, et al.
European Journal of Pharmacology|July 14, 2019
JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factorKenji Fukui, Yuichi Shinozaki, Hatsue Kobayashi, et al.
Kidney International|July 20, 2018
Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic miceShinji Tanaka, Yuki Sugiura, Hisako Saito, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Multiple instance learning using pathology foundation models effectively predicts kidney disease diagnosis and clinical classificationYu Kurata, Imari Mimura, Satoshi Kodera, et al.
Kidney International|March 23, 2005
A biologic role of HIF-1 in the renal medullaKrissanapong Manotham, Tetsuhiro Tanaka, Takamoto Ohse, et al.
Kidney International|April 3, 2018
Intravital phosphorescence lifetime imaging of the renal cortex accurately measures renal hypoxiaYosuke Hirakawa, Kiichi Mizukami, Toshitada Yoshihara, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Kidney International|January 17, 2009
Metallothionein is upregulated by hypoxia and stabilizes hypoxia-inducible factor in the kidneyIchiro Kojima, Tetsuhiro Tanaka, Reiko Inagi, et al.
American Journal of Physiology. Renal Physiology|June 4, 2010
Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stressFredrik Palm, Masaomi Nangaku, Angelica Fasching, et al.
Kidney International|March 16, 2020
The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney diseaseSho Hasegawa, Tetsuhiro Tanaka, Tomoyuki Saito, et al.
Scientific Reports|August 14, 2023
Chromatin remodeling factor, INO80, inhibits PMAIP1 in renal tubular cells via exchange of histone variant H2A.Z. for H2ARika Miura, Imari Mimura, Hanako Saigusa, et al.
Biochemical and Biophysical Research Communications|July 16, 2021
A novel method for successful induction of interdigitating process formation in conditionally immortalized podocytes from mice, rats, and humansKotaro Doi, Hiroshi Kimura, Takehiko Wada, et al.
European Journal of Pharmacology|July 14, 2019
JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factorKenji Fukui, Yuichi Shinozaki, Hatsue Kobayashi, et al.
Kidney International|July 20, 2018
Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic miceShinji Tanaka, Yuki Sugiura, Hisako Saito, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Multiple instance learning using pathology foundation models effectively predicts kidney disease diagnosis and clinical classificationYu Kurata, Imari Mimura, Satoshi Kodera, et al.
Kidney International|March 23, 2005
A biologic role of HIF-1 in the renal medullaKrissanapong Manotham, Tetsuhiro Tanaka, Takamoto Ohse, et al.
Kidney International|April 3, 2018
Intravital phosphorescence lifetime imaging of the renal cortex accurately measures renal hypoxiaYosuke Hirakawa, Kiichi Mizukami, Toshitada Yoshihara, et al.
Pageof 15